Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)
Recruiting
Phase 3
Interventional Study
Opioid Use Disorder
Pregnancy Related
Pregnancy, High Risk
Pregnancy Complications
Buprenorphine Withdrawal
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 110
- Sex
- Female
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Washington University School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare buprenorphine patch for induction (starting) of buprenorphine in pregnant patients with opioid use disorder. The main questions it aims to answer are:
1. Is there a buprenorphine induction method that results in the least moderate-to-severe opioid withdrawal symptoms in pregnant patients with opioid use disorder?
2. Is there a buprenorphine induction …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Viable pregnancy
* Meet diagnostic criteria for opioid use disorder
* Receive prenatal care through opioid use disorder specific clinic at our institution
* Opioid use within 24 hours prior to presentation
* Desire treatment with buprenorphine
Exclusion Criteria:
* Patients …
Contacts